E-LIB Suche - Ergebnisse für: Schultz, Armin

1

Challenges in the Development of Intravenous Neurokinin‐1 R..:

Tyler, Timothy ; Schultz, Armin ; Venturini, Alessio...
Clinical Pharmacology in Drug Development. 11 (2022) 12 - p. 1405-1418 , 2022

Link: https://doi.org/10.1002/..

2

Phase I studies of BI 1015550, a preferential phosphodieste..:

Maher, Toby M. ; Schlecker, Christina ; Luedtke, Doreen...
ERJ Open Research. 8 (2022) 4 - p. 00240-2022 , 2022

Link: https://doi.org/10.1183/..

3

Publisher Correction: COVID-19 vaccine BNT162b1 elicits hum..:

Sahin, Ugur ; Muik, Alexander ; Derhovanessian, Evelyna...
Nature. 590 (2021) 7844 - p. E17-E17 , 2021

Link: https://doi.org/10.1038/..

4

Pharmacokinetics, Safety, and Tolerability of the α2C‐Adren..:

Kapsa, Stefanie ; Thuss, Uwe ; Boxnick, Stefanie...
Clinical Pharmacology in Drug Development. 11 (2021) 3 - p. 296-308 , 2021

Link: https://doi.org/10.1002/..

5

Bioequivalence of macitentan and tadalafil given as fixed‐d..:

Grill, Simon ; Bruderer, Shirin ; Sidharta, Patricia N....
British Journal of Clinical Pharmacology. 86 (2020) 12 - p. 2424-2434 , 2020

Link: https://doi.org/10.1111/..

6

Midazolam microdosing applied in early clinical development..:

Wiebe, Sabrina T. ; Huennemeyer, Andreas ; Kadus, Werner...
British Journal of Clinical Pharmacology. 87 (2020) 1 - p. 178-188 , 2020

Link: https://doi.org/10.1111/..

7

Safety, pharmacokinetics and pharmacodynamics of BI 705564,..:

Litzenburger, Tobias ; Steffgen, Jürgen ; Benediktus, Ewald...
British Journal of Clinical Pharmacology. 87 (2020) 4 - p. 1824-1838 , 2020

Link: https://doi.org/10.1111/..

8

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T ..:

Sahin, Ugur ; Muik, Alexander ; Derhovanessian, Evelyna...
Nature. 586 (2020) 7830 - p. 594-599 , 2020

Link: https://doi.org/10.1038/..

9

Effect of Macitentan on the Pharmacokinetics of the Breast ..:

Csonka, Dénes ; Bruderer, Shirin ; Schultz, Armin...
Clinical Drug Investigation. 39 (2019) 12 - p. 1223-1232 , 2019

Link: https://doi.org/10.1007/..

10

Pharmacokinetics, Safety, and Tolerability of the Novel Chy..:

Kanefendt, Friederike ; Thuß, Uwe ; Becka, Michael...
Clinical Pharmacology in Drug Development. 8 (2018) 4 - p. 467-479 , 2018

Link: https://doi.org/10.1002/..

11

Pharmacokinetic Interaction between Faldaprevir and Cyclosp..:

Huang, Fenglei ; Voelk, Claudia ; Trampisch, Matthias...
Basic & Clinical Pharmacology & Toxicology. 123 (2018) 1 - p. 84-93 , 2018

Link: https://doi.org/10.1111/..

12

Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor,..:

Moschetti, Viktoria ; Schlecker, Christina ; Wind, Sven...
Clinical Drug Investigation. 38 (2018) 8 - p. 737-750 , 2018

Link: https://doi.org/10.1007/..

13

[P3–014]: INVESTIGATION OF PHARMACOKINETIC DRUG‐DRUG INTERA..:

Wunderlich, Glen ; Schultheis, Christian ; Link, Jasmin..
Alzheimer's & Dementia. 13 (2017) 7S_Part_19 - p. , 2017

Link: https://doi.org/10.1016/..

14

P1‐061: Pharmacokinetics of Single and Multiple Rising Dose..:

Moschetti, Viktoria ; Schlecker, Christina ; Schultz, Armin...
Alzheimer's & Dementia. 12 (2016) 7S_Part_8 - p. , 2016

Link: https://doi.org/10.1016/..

15

Effect of faldaprevir on raltegravir pharmacokinetics in he..:

Joseph, David ; Rose, Peter ; Strelkowa, Natalja...
The Journal of Clinical Pharmacology. 55 (2014) 4 - p. 384-391 , 2014

Link: https://doi.org/10.1002/..